Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Goodwill & Intangibles (2024 - 2025)

Caris Life Sciences has reported Goodwill & Intangibles over the past 2 years, most recently at $19.3 million for Q4 2025.

  • Quarterly results put Goodwill & Intangibles at $19.3 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $19.3 million (changed 0.0% YoY), and the annual figure for FY2025 was $19.3 million, changed 0.0%.
  • Goodwill & Intangibles for Q4 2025 was $19.3 million at Caris Life Sciences, roughly flat from $19.3 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for CAI hit a ceiling of $19.3 million in Q4 2024 and a floor of $19.3 million in Q4 2024.